Poseida Therapeutics slides on pricing $70 mln equity offering

Poseida Therapeutics

04/08/2022 13:31

** Shares of Poseida Therapeutics Inc  PSTX.O  down 18.2% at
$3.69 premarket after follow-on prices
    ** Genetic engineering platform sells 20 mln shares at
$3.50, raises $70 mln  urn:newsml:reuters.com:*:nPn4vBYhMa
    ** Shares on Weds surged 85.6% to close at $4.51 after co
inked deal with Roche  ROG.S  to develop therapies for blood
tissue cancers  urn:newsml:reuters.com:*:nL4N2ZF2ZM
    ** Offering represents about a third of co's shares
outstanding and roughly half of its public float, per Refinitiv
data
    ** Piper Sandler, William Blair, Cantor Fitzgerald and BTIG
acting as bookrunners


 (Lance Tupper is a Reuters market analyst. The views expressed
are his own)
 ((lance.tupper@thomsonreuters.com
lance.tupper@tr.com 1-332-219-1430))